Donald Hooker
Stock Analyst at Keybanc
(2.50)
# 2,456
Out of 5,090 analysts
81
Total ratings
55.95%
Success rate
9.22%
Average return
Main Sectors:
Stocks Rated by Donald Hooker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $180 → $100 | $7.59 | +1,217.52% | 18 | Feb 23, 2022 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $450 → $390 | $184.31 | +111.60% | 5 | Feb 17, 2022 | |
| DGX Quest Diagnostics | Maintains: Overweight | $168 → $170 | $182.51 | -6.85% | 4 | Dec 13, 2021 | |
| IQV IQVIA Holdings | Maintains: Overweight | $270 → $290 | $225.85 | +28.40% | 4 | Nov 17, 2021 | |
| PHR Phreesia | Maintains: Overweight | $70 → $73 | $20.29 | +259.78% | 8 | Jul 12, 2021 | |
| RXRX Recursion Pharmaceuticals | Initiates: Overweight | $36 | $4.71 | +664.33% | 1 | May 11, 2021 | |
| AMWL American Well | Initiates: Sector Weight | n/a | $4.01 | - | 1 | Apr 16, 2021 | |
| VEEV Veeva Systems | Maintains: Overweight | $332 → $353 | $242.00 | +45.87% | 2 | Feb 17, 2021 | |
| HQY HealthEquity | Downgrades: Sector Weight | n/a | $94.51 | - | 11 | Dec 2, 2020 | |
| MMS Maximus | Maintains: Overweight | $80 → $84 | $84.67 | -0.79% | 2 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.94 | - | 8 | Jul 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $212 → $170 | $258.39 | -34.21% | 7 | Mar 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $185.80 | - | 6 | Sep 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $68 → $46 | $1.36 | +3,282.35% | 2 | Nov 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $548.12 | - | 2 | Jul 10, 2017 |
Teladoc Health
Feb 23, 2022
Maintains: Overweight
Price Target: $180 → $100
Current: $7.59
Upside: +1,217.52%
Charles River Laboratories International
Feb 17, 2022
Maintains: Overweight
Price Target: $450 → $390
Current: $184.31
Upside: +111.60%
Quest Diagnostics
Dec 13, 2021
Maintains: Overweight
Price Target: $168 → $170
Current: $182.51
Upside: -6.85%
IQVIA Holdings
Nov 17, 2021
Maintains: Overweight
Price Target: $270 → $290
Current: $225.85
Upside: +28.40%
Phreesia
Jul 12, 2021
Maintains: Overweight
Price Target: $70 → $73
Current: $20.29
Upside: +259.78%
Recursion Pharmaceuticals
May 11, 2021
Initiates: Overweight
Price Target: $36
Current: $4.71
Upside: +664.33%
American Well
Apr 16, 2021
Initiates: Sector Weight
Price Target: n/a
Current: $4.01
Upside: -
Veeva Systems
Feb 17, 2021
Maintains: Overweight
Price Target: $332 → $353
Current: $242.00
Upside: +45.87%
HealthEquity
Dec 2, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $94.51
Upside: -
Maximus
Aug 7, 2020
Maintains: Overweight
Price Target: $80 → $84
Current: $84.67
Upside: -0.79%
Jul 6, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $3.94
Upside: -
Mar 30, 2020
Maintains: Overweight
Price Target: $212 → $170
Current: $258.39
Upside: -34.21%
Sep 23, 2019
Downgrades: Sector Weight
Price Target: n/a
Current: $185.80
Upside: -
Nov 13, 2017
Maintains: Overweight
Price Target: $68 → $46
Current: $1.36
Upside: +3,282.35%
Jul 10, 2017
Downgrades: Sector Weight
Price Target: n/a
Current: $548.12
Upside: -